Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Glass LF"'
Autor:
Jonathan S. Zager, Glass Lf, Ren Chen, Jane L. Messina, Divya Sadhwani, Drazen M. Jukic, Sumeet Thareja, Suroosh S. Marzban, Shalini Thareja
Publikováno v:
The American Journal of Dermatopathology. 36:64-67
Studies have suggested that elevated tumor mitotic rate (MR) is linked to overall survival in thin melanoma. Recently, promising data regarding anti-phosphohistone 3 (pHH3) immunohistochemistry and its ability to aid in calculation of MR have emerged
Autor:
Vernon K. Sondak, Michelle R. Iannacone, Anna R. Giuliano, Tarik Gheit, Matthew Kienstra, Massimo Tommasino, Jane L. Messina, C. Wayne Cruse, Tim Waterboer, Glass Lf, Neil A. Fenske, Michael Pawlita, Dana E. Rollison, Kristina M. Michael
Publikováno v:
International Journal of Cancer. 123:2337-2342
Cutaneous human papillomavirus (HPV) may be associated with the development of nonmelanoma skin cancer (NMSC), as suggested by reports of HPV DNA in NMSC tumors. HPV has also been investigated as an NMSC risk factor in epidemiologic studies, although
Publikováno v:
Surgical Oncology Clinics of North America. 8:427-434
The techniques of lymphatic mapping and sentinel lymph node biopsy are effective methods of accurately staging melanoma patients and identifying those who may benefit from further surgery or adjuvant chemotherapy. This article describes a standard pa
Autor:
Glass Lf, Cruse Cw, Jane L. Messina, Fadi F. Haddad, Claudia Berman, Brobeil A, Douglas S. Reintgen, Marshburn J
Publikováno v:
Surgical Oncology Clinics of North America. 8:435-445
In the current era of managed care and cost containment, physicians and administrators are placed in the predicament of increasing quality of care while decreasing costs. The purpose of this article is to offer a cost analysis, while also demonstrati
Autor:
Douglas S. Reintgen, Ronald C. DeConti, Glass Lf, Mark J. Jaroszeski, Richard Gilbert, Richard Heller, A P A Chris Puleo
Publikováno v:
Cancer. 83:148-157
BACKGROUND Electrochemotherapy (ECT) is performed by locally administering a chemotherapeutic agent in combination with electric pulses. Previous clinical studies have demonstrated the effectiveness of ECT. In these initial trials, the drug was admin
Publikováno v:
Cancer Control. 5:11-18
Background: Cutaneous T-cell lymphoma (CTCL) represents a spectrum of diseases composed of malignant helper T lymphocytes. An accurate diagnosis of early CTCL is difficult because of the varied clinical and histologic expressions of the disease. Meth
Publikováno v:
International Journal of Dermatology. 36:801-809
Publikováno v:
Journal of the American Academy of Dermatology. 37:596-599
Background: A new anticancer therapy, electrochemotherapy (ECT), has been introduced that entails exposing cancerous tissues to short pulses of electricity during chemotherapy. This enhances cell membrane permeability and has been shown to have poten
Autor:
Claudia Berman, G. Miliotes, Glass Lf, Neil A. Fenske, Rapaport D, Jane L. Messina, Douglas S. Reintgen, Wells Ke, Wayne Cruse
Publikováno v:
Dermatologic Surgery. 22:715-720
background Selective lymphadenectomy or “sentinel node” biopsy Ms been introduced recently by Morton and colleagues (Arch Surg 1992;127:392–9) to stage patients with intermediate and thick malignant melanomas. It has proven to be an effective w
Autor:
Richard Heller, Cruse Cw, Wells Ke, Ronald C. DeConti, Neil A. Fenske, Claudia Berman, J. Albertini, Glass Lf, Rapaport D, Xiangning Wang, Christopher A. Puleo, Douglas S. Reintgen, Jane L. Messina
Publikováno v:
Cancer Control. 2:405-414
The incidence of malignant melanoma is increasing at a faster pace than that of any other cancer in the United States. It is estimated that people born in the year 2000 will have a 1:75 risk of developing melanoma sometime during his or her lifetime.